One of the main predictors of respiratory function in the newborn is presence of an adequate area of the gas-exchanging epithelium. This surface area is directly correlated with fetal lung volume. Therefore, it is rational to evaluate the fetal lung volumes in the uterus with the purpose of detection of hypoplastic lungs (
18).
Pulmonary hypoplasia is associated with a high rate of neonatal morbidity and mortality. For selected causes of pulmonary hypoplasia, prenatal intervention is available. For all prognoses, management and follow-up schedules depend on the degree of hypoplasia and volume of the remaining lung tissue. Thus, such fetuses could benefit from antenatal detection of restricted pulmonary development. In order to call a lung small-sized or underdeveloped, comparison with a valid, population based, normal reference value is necessary.
Since the 1980s (
19), fetal MR has been used as a competent, non-invasive, and harmless modality to study fetal lung development after 18 gestational weeks (GW) in the uterus. In addition to the prior role of MRI in the evaluation of lung growth, the high resolution and tissue contrast of MRI allows us to study the structure of the fetal lung and more detailed fetal pulmonary pathologies. So far, few studies have applied fetal MR lung volumetry to evaluate the lung volume of normal fetuses (
12,
20) to establish a reference data for detection of fetuses with abnormally small lungs (
9,
21).
Fetal MRI is typically performed due to abnormal results found at anatomical surveys generally performed around 18 weeks of gestation. Before 18 weeks of gestation, because of the limitations in spatial resolution and difficulty in the diagnosis of anomalies including congenital diaphragmatic hernia (CDH), fetal MRI is hardly used. Although fetal MRI becomes increasingly more accurate in the later gestational ages, restrictions imposed by age of legal abortion in most countries necessitate earlier diagnosis. However, in most studies of normal fetal lung volumes- this early period (18 - 22 weeks GA) is under-represented despite its significance (
13,
16).
Our study complements previous research of the volumetric assessment of fetal lung growth.
There is high inconsistency in total lung volumes as reported by different investigators. In the lack of universally accepted standardized values, this wide range of data generates the likelihood of overlap between normal and abnormal fetal lung volume values.
Rypens et al. (
16) estimated FLV at 21 - 38 weeks gestation in 215 fetuses without thoracoabdominal malformations and with normal US biometric findings (range, 16 - 150 mL) increased with gestational age. However, Meyers et al. (
17) showed that the measured mean total fetal lung volume values at 19 - 22 weeks were significantly lower than those predicted by the Rypens formula. Although the obtained volumes in our study were lower than the data of mentioned studies at every gestational week, the differences are much noticeable at older gestational age which could be due to biologic variation. This will enhance the possibility of overlap with hypoplastic lung volumes in late pregnancy. At 19 - 22 weeks, our results were more similar to those of Meyers et al. (
17) than Rypens et al. (
16) There was a higher number of measurements made in this gestational age range in our study and the study performed by Meyers et al. (
17) compared to the study conducted by Rypens et al. (
16). Our data in this time period was closer to Meyers dataset. Meanwhile, our data set later in pregnancy was significantly lower than both studies. This difference between our study and the two mentioned studies could be related to many factors including the different ethnicities, and different measurement techniques.
On the other hand, several studies have also stated race-based variances in gestational age-specific birth weights. Wang et al. (
22) showed that the gestational age-specific mean birth weights of white American babies were higher than those of Japanese babies. The mentioned relationship could be extended to the lung volume, considering the different results of studies for estimation of the normal lung volume in each country. As described before, our result showed the most similarity to the study conducted by Osada et al. (
9) which owned the closest match to the race of our population compared to European and American populations in a study performed by Rypens et al. (
16) and Meyers et al. (
17), respectively. Therefore, it could be concluded that offering a single worldwide practical data base for fetal lung volume is not rational.
As one of the limitations of our study, it should be mentioned that sampling was not performed among a strictly healthy population and it may involve fetuses with structural abnormalities outside the chest cavity referred for prenatal MR imaging. However, this selection limitation was minimized by excluding the fetuses with thoracic abnormalities and other intervening factors, and the measurements obtained in the subjects of the study represent rational estimates of normal lung development.
Second, lung volume measurements may alter with the cardiac cycle or fetal breathing. In this study, such effect tried to be degraded via the acquisition time and by multiple measurements and obtaining a mean fetal lung volume. Third, two plane measurement and 3-D volumetry were not accessible for comparison.
In conclusion, the lung volume can be predicted with a high degree of accuracy in fetuses with the same biological alterations through each gestational age by developing prenatal MR imaging lung volumetry to avoid and prepare for neonatal respiratory problems which are responsible for a high rate of mortality and morbidity.